A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer

Authors

Institutions

Publication Details

Journal
Cancer Chemotherapy and Pharmacology
Published
2026-01-06
DOI
https://doi.org/10.1007/s00280-025-04846-w
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
36.44
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer

Karen Urtishak, Anuradha Jayaram, Ligi Mathews, Nicholas A. Zorko et al.
1 citations
Cancer Chemotherapy and Pharmacology
Prostate Cancer Treatment and Research
36.44
article

A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer

Karen Urtishak, Anuradha Jayaram, Ligi Mathews, Nicholas A. Zorko, Peter Francis, D. Ghosh, Brent Rupnow, Kevin Zarrabi, Edward F. Attiyeh, Johann Sebastian De Bono, Sherry Wang, Andrew Hudson, Mengjie Li, Benjamin Garmezy
article en
1 citations

Abstract

No abstract available for this paper.
Cancer Chemotherapy and PharmacologyVol. 96(1)
University of Minnesota (US), Royal Marsden NHS Foundation Trust (GB), Johnson & Johnson (United States) (US), Thomas Jefferson University Hospital (US), Sarah Cannon (US), The Christie NHS Foundation Trust (GB)
Good health and well-being
Openalex Percentile: Top 2%
Prostate Cancer Treatment and Research
36.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.